Evidence map›Paper›PMID 30394380›Full record

ArticleJournal of visualized experiments : JoVE2018

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips.

Richard Novak, Meredyth Didier, Elizabeth Calamari, Carlos F Ng, Youngjae Choe, Susan L Clauson, Bret A Nestor, Jefferson Puerta, Rachel Fleming, Sasan J Firoozinezhad and 1 more

Erratum issuedOpen access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Augmented 3D Printing for Multiscale Microphysiological Systems.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Polymeric nanoparticles as therapeutic agents against coronavirus disease.Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology · 2022
    Review
  13. Review
  14. Rapid Prototyping of Multilayer Microphysiological Systems.ACS biomaterials science & engineering · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Richard NovakWyss Institute for Biologically Inspired Engineering, Harvard University; richard.novak@wyss.harvard.edu.
Meredyth DidierWyss Institute for Biologically Inspired Engineering, Harvard University; Apple, Inc.
Elizabeth CalamariWyss Institute for Biologically Inspired Engineering, Harvard University.
Carlos F NgWyss Institute for Biologically Inspired Engineering, Harvard University.
Youngjae ChoeWyss Institute for Biologically Inspired Engineering, Harvard University.
Susan L ClausonWyss Institute for Biologically Inspired Engineering, Harvard University.
Bret A NestorWyss Institute for Biologically Inspired Engineering, Harvard University.
Jefferson PuertaWyss Institute for Biologically Inspired Engineering, Harvard University.
Rachel FlemingWyss Institute for Biologically Inspired Engineering, Harvard University.
Sasan J FiroozinezhadWyss Institute for Biologically Inspired Engineering, Harvard University.
Donald E IngberWyss Institute for Biologically Inspired Engineering, Harvard University; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School.
Inspire · CHBoston Children's Hospital · US

Funding

Lung-on-a-Chip Disease Models for Efficacy TestingUG3HL141797 · NHLBI · HARVARD UNIVERSITY · PI INGBER, DONALD E · 2017 to 2018
$2.8M
Mechanotransduction analysis in a microengineered lung-on-a-chipR01EB020004 · NIBIB · HARVARD MEDICAL SCHOOL · PI INGBER, DONALD E · 2015 to 2018
$2.5M
FDA HHS HHSF223201310079CNHLBI NIH HHS UG3 HL141797NIBIB NIH HHS R01 EB020004
6 · The paper itself

Abstract

A significant number of lead compounds fail in the pharmaceutical pipeline because animal studies often fail to predict clinical responses in human patients. Human Organ-on-a-Chip (Organ Chip) microfluidic cell culture devices, which provide an experimental in vitro platform to assess efficacy, toxicity, and pharmacokinetic (PK) profiles in humans, may be better predictors of therapeutic efficacy and safety in the clinic compared to animal studies. These devices may be used to model the function of virtually any organ type and can be fluidically linked through common endothelium-lined microchannels to perform in vitro studies on human organ-level and whole body-level physiology without having to conduct experiments on people. These Organ Chips consist of two perfused microfluidic channels separated by a permeable elastomeric membrane with organ-specific parenchymal cells on one side and microvascular endothelium on the other, which can be cyclically stretched to provide organ-specific mechanical cues (e.g., breathing motions in lung). This protocol details the fabrication of flexible, dual channel, Organ Chips through casting of parts using 3D printed molds, enabling combination of multiple casting and post-processing steps. Porous poly (dimethyl siloxane) (PDMS) membranes are cast with micrometer sized through-holes using silicon pillar arrays under compression. Fabrication and assembly of Organ Chips involves equipment and steps that can be implemented outside of a traditional cleanroom. This protocol provides researchers with access to Organ Chip technology for in vitro organ- and body-level studies in drug discovery, safety and efficacy testing, as well as mechanistic studies of fundamental biological processes.

Indexed as

AnimalsCell Culture TechniquesHumansMicrofluidics

Identifiers

PMID30394380
PMCPMC6235575
OpenAlexW2897518813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.